Diabetes Care Devices Market Report 2026

Diabetes Care Devices Market Overview

• Diabetes Care Devices market size has reached to $73.91 billion in 2025 • Expected to grow to $130.76 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Rising Healthcare Expenditures Expected To Propel Diabetes Care Device Market Growth • Market Trend: Advancements In Continuous Glucose Monitoring Technology • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Diabetes Care Devices Market?

Diabetes care devices are used to monitor and control blood glucose levels in diabetic patients. Diabetes care devices are designed to help manage and monitor blood glucose levels, allowing people with diabetes to maintain better control of their condition and minimize health risks. The main types of diabetes care devices are blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are injection devices with a needle that delivers insulin into the subcutaneous tissue. The types of expenditures are public and private, and the products used are instruments/equipment and disposables. The various types of testing are point of care (POC) testing, and non-point of care (POC) testing and used by various end-users such as hospitals and clinics, diagnostic laboratories, and others.

What Is The Diabetes Care Devices Market Growth Forecast?

The diabetes care devices market size is expected to see rapid growth in the next few years. It will grow to $130.76 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for real-time glucose monitoring, rising adoption of closed-loop insulin systems, expansion of digital diabetes management platforms, growing focus on personalized diabetes care, increasing healthcare investments in chronic disease management. Major trends in the forecast period include increasing adoption of continuous glucose monitoring devices, rising use of smart insulin delivery systems, growing integration of mobile health platforms, expansion of connected diabetes management ecosystems, enhanced focus on patient-centric monitoring solutions.

Global Diabetes Care Devices Market Segmentation

1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters 2) By Type of Expenditure: Public, Private 3) By Consumable Type: Instruments Or Equipment, Disposables 4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing 5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users Subsegments: 1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors 2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens 3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes 4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps 5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges) 6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters 7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

What Is The Driver Of The Diabetes Care Devices Market?

Increasing healthcare expenditures are anticipated to propel the growth of the diabetes care device market going forward. Healthcare expenditures refer to the total amount spent on healthcare-related services, products, and activities within a specified period, typically on an individual, community, national, or global level. The increasing healthcare expenditures, coupled with greater access to healthcare services and rising diabetes diagnoses, drive heightened investments in research and development, leading to the advancement of diabetes care devices such as improved glucose monitoring systems, insulin delivery devices, and digital health solutions. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, National Health Expenditure (NHE) grew 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures grew 10.4% to $1,519.7 billion in 2023, faster than the 3.2% growth in 2022. Therefore, increasing healthcare expenditure will drive the growth of the diabetes care device industry going forward.

Key Players In The Global Diabetes Care Devices Market

Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited

Global Diabetes Care Devices Market Trends and Insights

Major companies operating in the diabetes care devices market are focusing on developing advanced solutions such as real-time glucose monitoring technology to enhance accuracy, convenience, and proactive disease management. Real-time glucose monitoring technology provides automatic continuous glucose readings and alerts that help people with diabetes make timely decisions and reduce health risks. For instance, in August 2025, Abbott Laboratories, a US-based healthcare company, launched the FreeStyle Libre 2 Plus, featuring continuous minute-by-minute glucose readings delivered directly to a compatible smartphone along with optional alarms for low or high glucose events. The device supports confident diabetes self-management by offering automatic alerts, historical trends, and directional arrows without routine fingersticks. It works through near-field communication and Bluetooth connectivity and can be worn for up to 15 days. It also enables caregivers to receive glucose updates through connected digital health tools. The device helps improve patient safety by supporting quick interventions and enhances engagement by providing real-time insights that guide daily health choices.

What Are Latest Mergers And Acquisitions In The Diabetes Care Devices Market?

In September 2025, Glooko Inc., a US-based provider of remote patient monitoring platforms, digital diabetes management solutions, and connected device integration tools, acquired Monarch Medical Technologies for an undisclosed amount. With this acquisition, Glooko aims to expand its connected diabetes care ecosystem into inpatient settings by integrating Monarch’s insulin-dosing technology to create a unified hospital-to-home glycemic management platform. Monarch Medical Technologies is a US-based provider of FDA-cleared inpatient glucose management software, offering the EndoTool system for precise, algorithm-driven insulin dosing in hospitals.

Regional Outlook

North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Diabetes Care Devices Market?

The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.